These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
186 related articles for article (PubMed ID: 15126340)
1. HOXB13 homeodomain protein suppresses the growth of prostate cancer cells by the negative regulation of T-cell factor 4. Jung C; Kim RS; Lee SJ; Wang C; Jeng MH Cancer Res; 2004 May; 64(9):3046-51. PubMed ID: 15126340 [TBL] [Abstract][Full Text] [Related]
2. HOXB13 induces growth suppression of prostate cancer cells as a repressor of hormone-activated androgen receptor signaling. Jung C; Kim RS; Zhang HJ; Lee SJ; Jeng MH Cancer Res; 2004 Dec; 64(24):9185-92. PubMed ID: 15604291 [TBL] [Abstract][Full Text] [Related]
3. HOXB13 is downregulated in colorectal cancer to confer TCF4-mediated transactivation. Jung C; Kim RS; Zhang H; Lee SJ; Sheng H; Loehrer PJ; Gardner TA; Jeng MH; Kao C Br J Cancer; 2005 Jun; 92(12):2233-9. PubMed ID: 15928669 [TBL] [Abstract][Full Text] [Related]
5. Recruitment of HDAC4 by transcription factor YY1 represses HOXB13 to affect cell growth in AR-negative prostate cancers. Ren G; Zhang G; Dong Z; Liu Z; Li L; Feng Y; Su D; Zhang Y; Huang B; Lu J Int J Biochem Cell Biol; 2009 May; 41(5):1094-101. PubMed ID: 19013255 [TBL] [Abstract][Full Text] [Related]
6. HOXB13-mediated suppression of p21WAF1/CIP1 regulates JNK/c-Jun signaling in prostate cancer cells. Kim YR; Kang TW; To PK; Xuan Nguyen NT; Cho YS; Jung C; Kim MS Oncol Rep; 2016 Apr; 35(4):2011-6. PubMed ID: 26781690 [TBL] [Abstract][Full Text] [Related]
7. Modulation of beta-catenin-mediated TCF-signalling in prostate cancer cell lines by wild-type and mutant p53. Prowald A; Cronauer MV; von Klot C; Eilers T; Rinnab L; Herrmann T; Spindler KD; Montenarh M; Jonas U; Burchardt M Prostate; 2007 Dec; 67(16):1751-60. PubMed ID: 17929268 [TBL] [Abstract][Full Text] [Related]
8. HOXB13 promotes androgen independent growth of LNCaP prostate cancer cells by the activation of E2F signaling. Kim YR; Oh KJ; Park RY; Xuan NT; Kang TW; Kwon DD; Choi C; Kim MS; Nam KI; Ahn KY; Jung C Mol Cancer; 2010 May; 9():124. PubMed ID: 20504375 [TBL] [Abstract][Full Text] [Related]
9. ATRA inhibits the proliferation of DU145 prostate cancer cells through reducing the methylation level of HOXB13 gene. Liu Z; Ren G; Shangguan C; Guo L; Dong Z; Li Y; Zhang W; Zhao L; Hou P; Zhang Y; Wang X; Lu J; Huang B PLoS One; 2012; 7(7):e40943. PubMed ID: 22808286 [TBL] [Abstract][Full Text] [Related]
10. HOXB13 regulates the prostate-derived Ets factor: implications for prostate cancer cell invasion. Kim IJ; Kang TW; Jeong T; Kim YR; Jung C Int J Oncol; 2014 Aug; 45(2):869-76. PubMed ID: 24898171 [TBL] [Abstract][Full Text] [Related]
12. MEIS1 down-regulation by MYC mediates prostate cancer development through elevated HOXB13 expression and AR activity. Whitlock NC; Trostel SY; Wilkinson S; Terrigino NT; Hennigan ST; Lake R; Carrabba NV; Atway R; Walton ED; Gryder BE; Capaldo BJ; Ye H; Sowalsky AG Oncogene; 2020 Aug; 39(34):5663-5674. PubMed ID: 32681068 [TBL] [Abstract][Full Text] [Related]
13. MEIS-mediated suppression of human prostate cancer growth and metastasis through HOXB13-dependent regulation of proteoglycans. VanOpstall C; Perike S; Brechka H; Gillard M; Lamperis S; Zhu B; Brown R; Bhanvadia R; Vander Griend DJ Elife; 2020 Jun; 9():. PubMed ID: 32553107 [TBL] [Abstract][Full Text] [Related]
14. The alternative splice variant of protein tyrosine kinase 6 negatively regulates growth and enhances PTK6-mediated inhibition of β-catenin. Brauer PM; Zheng Y; Evans MD; Dominguez-Brauer C; Peehl DM; Tyner AL PLoS One; 2011 Mar; 6(3):e14789. PubMed ID: 21479203 [TBL] [Abstract][Full Text] [Related]
15. Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells. Tetsu O; McCormick F Nature; 1999 Apr; 398(6726):422-6. PubMed ID: 10201372 [TBL] [Abstract][Full Text] [Related]
16. The homeodomain protein HOXB13 regulates the cellular response to androgens. Norris JD; Chang CY; Wittmann BM; Kunder RS; Cui H; Fan D; Joseph JD; McDonnell DP Mol Cell; 2009 Nov; 36(3):405-16. PubMed ID: 19917249 [TBL] [Abstract][Full Text] [Related]
17. HOXB13 interaction with MEIS1 modifies proliferation and gene expression in prostate cancer. Johng D; Torga G; Ewing CM; Jin K; Norris JD; McDonnell DP; Isaacs WB Prostate; 2019 Mar; 79(4):414-424. PubMed ID: 30560549 [TBL] [Abstract][Full Text] [Related]
18. Negative regulation of c-Myc transcription by pancreas duodenum homeobox-1. Chen L; Yan HX; Chen J; Yang W; Liu Q; Zhai B; Cao HF; Liu SQ; Wu MC; Wang HY Endocrinology; 2007 May; 148(5):2168-80. PubMed ID: 17317781 [TBL] [Abstract][Full Text] [Related]
19. Positive inter-regulation between beta-catenin/T cell factor-4 signaling and endothelin-1 signaling potentiates proliferation and survival of prostate cancer cells. Sun P; Xiong H; Kim TH; Ren B; Zhang Z Mol Pharmacol; 2006 Feb; 69(2):520-31. PubMed ID: 16291872 [TBL] [Abstract][Full Text] [Related]
20. Regulation of smooth muscle cell proliferation by beta-catenin/T-cell factor signaling involves modulation of cyclin D1 and p21 expression. Quasnichka H; Slater SC; Beeching CA; Boehm M; Sala-Newby GB; George SJ Circ Res; 2006 Dec; 99(12):1329-37. PubMed ID: 17122440 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]